Cytokinetics (CYTK) Treasury Shares: 2011-2024
Historic Treasury Shares for Cytokinetics (CYTK) over the last 6 years, with Dec 2024 value amounting to $1.9 million.
- Cytokinetics' Treasury Shares rose 35.68% to $1.9 million in Q4 2024 from the same period last year, while for Dec 2024 it was $1.9 million, marking a year-over-year increase of 35.68%. This contributed to the annual value of $1.9 million for FY2024, which is 35.68% up from last year.
- According to the latest figures from Q4 2024, Cytokinetics' Treasury Shares is $1.9 million, which was up 35.68% from $1.4 million recorded in Q4 2023.
- Cytokinetics' 5-year Treasury Shares high stood at $1.9 million for Q4 2024, and its period low was $1.1 million during Q4 2020.
- Its 3-year average for Treasury Shares is $1.5 million, with a median of $1.4 million in 2023.
- As far as peak fluctuations go, Cytokinetics' Treasury Shares dropped by 14.18% in 2022, and later skyrocketed by 35.68% in 2024.
- Quarterly analysis of 5 years shows Cytokinetics' Treasury Shares stood at $1.1 million in 2020, then grew by 26.70% to $1.4 million in 2021, then decreased by 14.18% to $1.2 million in 2022, then rose by 13.21% to $1.4 million in 2023, then soared by 35.68% to $1.9 million in 2024.
- Its Treasury Shares stands at $1.9 million for Q4 2024, versus $1.4 million for Q4 2023 and $1.2 million for Q4 2022.